eMurmur Heart AI vs EchoNext

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eMurmur Heart AI

by CSD Labs

EchoNext

by Pathway Labs

AI Verdict

eMurmur Heart AI and EchoNext both offer FDA-cleared AI solutions for cardiac assessment, making them adjacent competitors. eMurmur Heart AI focuses on analyzing heart and lung sounds via auscultation for murmur detection and hemodynamic insights, suitable for real-time screening and monitoring. In contrast, EchoNext analyzes standard ECGs to detect hidden structural heart disease, including heart failure and valve disease, providing a different diagnostic approach for cardiac conditions.

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if your primary need is automated, AI-powered analysis of heart and lung sounds for the detection and classification of murmurs, crackles, and wheezes. This tool is ideal for telehealth, remote monitoring, and bedside auscultation, especially when leveraging various digital stethoscopes and requiring secure storage and comparison of auscultation data over time.

View eMurmur Heart AI →

Choose EchoNext if…

Choose EchoNext if your focus is on detecting hidden structural heart disease, such as heart failure, valve disease, and pulmonary hypertension, through the analysis of standard 12-lead ECGs. This tool is particularly well-suited for broad screening in various clinical settings, from major hospitals to community practices, to identify patients who may require further cardiac imaging like echocardiograms.

View EchoNext →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eMurmur Heart AI	EchoNext
Pricing	Contact for pricing.	Starts at $600/month
Deployment	Cloud-based, Web application, Mobile app	Available through the OpenEvidence clinical decision support platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

eMurmur Heart AI offers broad compatibility with various digital stethoscopes and is available as a mobile app and web portal, providing flexibility for different healthcare settings and workflows. Its emphasis on recording, comparison over time, and AI-assisted review within a user-friendly interface suggests a strong focus on practical usability for clinicians.

Clinical Value

EchoNext

EchoNext demonstrates superior clinical value by accurately identifying a broad range of structural heart diseases from standard ECGs, outperforming cardiologists in head-to-head comparisons, even when cardiologists were AI-assisted. This capability allows for earlier detection of critical conditions that might otherwise be missed, potentially leading to earlier, life-saving interventions.

Pricing & Value

EchoNext

EchoNext offers transparent tiered pricing starting at $600/month, including different plans for various organizational sizes and an annual discount. This transparency allows potential users to better understand the cost. eMurmur Heart AI requires contacting them for pricing, which makes it less transparent upfront.

Enterprise Readiness

eMurmur Heart AI

eMurmur Heart AI explicitly states HIPAA and GDPR compliance, offers a Business Associate Agreement (BAA), and provides secure data storage options in the US or EU. Its hardware-neutral and stethoscope-agnostic platform compatibility, along with API integration options, suggests strong enterprise readiness for diverse IT environments.

Innovation

Tie

Both tools demonstrate significant innovation in their respective domains. eMurmur Heart AI innovates by providing an open, hardware-agnostic AI layer for auscultation, enabling broad integration across different stethoscopes and third-party software for heart and lung sound analysis. EchoNext is innovative as the first FDA-cleared AI tool to detect hidden structural heart disease from standard ECGs, effectively expanding the diagnostic capabilities of a widely used, inexpensive test.

Support & Docs

eMurmur Heart AI

eMurmur Heart AI provides readily accessible FAQs and a clear contact for sales and support, indicating a structured approach to customer assistance. While EchoNext is collaborating with OpenEvidence to expand access, specific details about direct customer support and documentation are less explicit in the provided information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eMurmur Heart AI	EchoNext
Name	eMurmur Heart AI	EchoNext
Company	CSD Labs	Pathway Labs
Description	FDA-cleared, AI-powered software platform for automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights. It supports digital stethoscopes, mobile apps, and web portals for screening, monitoring, and remote consultation in various healthcare settings.	FDA-cleared AI tool that analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.
Key Features	Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), Detection and classification of pathologic and innocent heart murmurs, Hemodynamic insights (loudness ratios of S1, systole, S2, diastole), Mobile app (iOS, Android) and web portal for access, Hardware-neutral and stethoscope agnostic platform compatibility, Live streaming and remote auscultation for telehealth, Recording, secure storage, and playback of auscultation data, Comparison of current and previous auscultation data for monitoring	AI-powered ECG analysis, Detection of hidden structural heart disease, Identifies heart failure risk, Screens for valve disease, Detects pulmonary hypertension indicators, Utilizes standard 12-lead ECGs, FDA-cleared technology, Non-invasive diagnostic support
Specialties	Cardiology, Internal Medicine, Pulmonology	Cardiology, Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring eMurmur Heart AI and EchoNext.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into existing clinical workflows for cardiac assessment?

eMurmur Heart AI integrates into workflows by supporting live streaming and remote auscultation, recording and storing data, and allowing comparison of current and previous auscultation data for monitoring. It can be accessed via mobile apps and web portals, and is compatible with various digital stethoscopes, making it suitable for telehealth, cardiology consults, and teaching environments. EchoNext, on the other hand, analyzes standard 12-lead ECGs and is designed to integrate with the OpenEvidence clinical decision support platform, aiming to put its screening output directly into tools physicians already use during patient visits, rather than requiring a separate system.

What is the depth of EHR integration offered by each tool?

eMurmur Heart AI offers secure storage and playback of auscultation data, and its web portal allows for retrieval of PDF reports containing results, which can facilitate integration into electronic medical records. EchoNext is available through the OpenEvidence clinical decision support platform, which suggests a level of integration that allows its screening outputs to be presented within a platform used by many clinicians, potentially streamlining the flow of information into the EHR.

What are the reported accuracy and sensitivity for detecting cardiac conditions with each tool?

eMurmur Heart AI has demonstrated high accuracy in detecting pathologic heart murmurs. Studies have shown sensitivity and specificity for detecting pathologic cases ranging from 84.4% to 93% and 81% to 97% respectively, with overall accuracy around 88-95%, depending on the certainty measure and patient population. EchoNext, an AI-powered ECG model, has shown an area under the receiver operating characteristic (AUROC) of 85.2% in internal tests and 78-80% in external validation for detecting structural heart disease. In comparisons with cardiologists, EchoNext achieved 77% accuracy, while cardiologists alone had 64% accuracy, and 69% with AI assistance.

For which specific cardiac specialties are these tools best suited?

eMurmur Heart AI is well-suited for cardiology, internal medicine, and pulmonology, with a focus on automated analysis of heart and lung sounds, detection of murmurs, and hemodynamic insights. It is particularly relevant for cardiology consult workflows, clinical documentation, and teaching. EchoNext is designed for cardiology, family medicine, hospital medicine, and internal medicine, as it analyzes standard ECGs to detect hidden structural heart disease, including heart failure, valve disease, and pulmonary hypertension.

What is the typical learning curve for physicians adopting these AI tools?

eMurmur Heart AI is designed for ease of use with a simple, proven user interface and real-time quality assurance algorithms. It operates through a web browser and mobile apps, and its hardware-neutral compatibility with various digital stethoscopes suggests a focus on integrating with existing equipment, potentially reducing the learning curve associated with new hardware. EchoNext is integrated into the OpenEvidence clinical decision support platform, which is used by many clinicians, suggesting that its use would leverage familiarity with that existing platform, potentially easing adoption.

Are there audit-trail features available for tracking the use and impact of the AI analysis?

The provided information does not explicitly detail specific audit-trail features for either eMurmur Heart AI or EchoNext. However, eMurmur Heart AI emphasizes recording, secure storage, and comparison of auscultation data over time, which could inherently support a level of tracking. EchoNext's integration with a clinical decision support platform suggests that its usage and outputs would likely be logged within that system, but explicit audit-trail functionalities are not described.